Novel Approaches for Oral Insulin Delivery - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Novel Approaches for Oral Insulin Delivery
The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin.


Pharmaceutical Technology
Volume 33, Issue 7

18. A.M. Lowman, "Oral Delivery of Insulin using pH-Sensitive Complexation Gels," J. Pharm. Sci. 88 (9), 933–937 (1999).

19. N.A. Peppas, "Devices based on Intelligent Biopolymers for Oral Protein Delivery," Int. J. Pharm. 277 (1–2), 11–17 (2004).

20. C. Ramkisson-Ganorkar, "Modulating Insulin Release Profile from pH/Thermosensitive Polymeric Beads through Polymer Molecular Weight," J. Control. Release 59 (3), 287–298 (1999).

21. K. Zhang and X.Y. Wu, "Temperature and pH Responsive Polymeric Composite Membranes for Controlled Delivery of Proteins and Peptides," Biomaterials 25 (22), 5281–5291 (2004).

22. C.P. Reis et al., "Alginate Microparticles as Novel Carrier for Oral Insulin Delivery," Biotechnol. Bioeng. 96 (5), 977–989 (2007).

23. H. Tozaki, "Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon," J. Pharm. Sci. 86 (9), 1016–1021 (1997).

24. U. Ubaidulla et al., "Chitosan Phthalate Microspheres for Oral Delivery of Insulin: Preparation, Characterization, and In Vitro Evaluation," Drug Delivery 14 (1), 19–23 (2007).

25. R. Qi and Q.N. Ping, "Gastrointestinal Absorption Enhancement of Insulin by Administration of Enteric Microspjeres and SNAC to Rats," J. Microencapsul. 21 (1), 37–45 (2004).

26. D. Senthil Rajan et al., "Oral Delivery System of Insulin Microspheres: Effect on Relative Hypoglycemia of Diabetic Albino Rats," Boll. Chim. Farm. 143 (8), 315–318 (2004).

27. B.Y. Kim et al., "Bioadhesive Interaction and Hypoglycemic Effect of Insulin-Loaded Lectin-Microparticle Conjugates in Oral Insulin Delivery System," J. Control. Release 102 (3), 525–38 (2005).

28. K.B. Choudhari and V. Labhasetwar, "Liposomes as a Carrier for Oral Administration of Insulin: Effect of Formulation Factors," J. Microencapsul. 11 (3), 319–325 (1994).

29. Z.H. Wu, "Hypoglyceamic Efficacy of Chitosan-Coated Insulin Liposomes after Oral Administration in Mice," Acta Pharmacol Sin. 25 (7), 966–972 (2004).

30. D. Cantenys et al., "Covalent Attachment of Insulin to the Outer Surface of Liposomes," Biochem. Biophys. Res. Commun. 117 (2), 399–405 (1983).

31. Q. Ye et al., "DepoFoam Technology: A Vehicle for Controlled Delivery of Protein and Peptide Drugs," J. Control. Release 14, (1–3), 155–66 (2000).

32. Z.H. Wu et al., "Studies on the Insulin-Liposomes Double-Coated by Chitosan and Chitosan-EDTA Conjugates," Yao Xue Xue Bao 39 (11), 933-938 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here